| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ability to culture resectable non-small cell lung carcinomas is correlated with recurrence
|
|
|
1995
|
12 |
3 |
p. 294-295
2 p.
|
artikel
|
| 2 |
Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history
|
|
|
1995
|
12 |
3 |
p. 273-274
2 p.
|
artikel
|
| 3 |
Absence of p16(INK4) protein is restricted to the subset of lung cancer lines that retains wildtype RB
|
|
|
1995
|
12 |
3 |
p. 273-
1 p.
|
artikel
|
| 4 |
A case of adenocarcinoma of the lung successfully treated by combination chemotherapy with cisplatin and vindesine, resulting in a long survival without recurrence and synchronous thyroid cancer
|
|
|
1995
|
12 |
3 |
p. 286-
1 p.
|
artikel
|
| 5 |
A case of G-CSF producing lung cancer detected on examination for leucocytosis
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 6 |
A case of peripheral epidermoid carcinoma showing a fungus ball-like shadow
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 7 |
A case of primary signet ring cell carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 289-
1 p.
|
artikel
|
| 8 |
A case of rapidly growing primary lung cancer producing alphafetoprotein
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 9 |
A case of small cell lung cancer associated with fulminant hepatitis B
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 10 |
A case of small cell lung cancer with both sarcoid reaction and metastasis in the regional lymph nodes
|
|
|
1995
|
12 |
3 |
p. 282-
1 p.
|
artikel
|
| 11 |
A case of synchronous multiple lung cancer with heterogeneous histological types
|
|
|
1995
|
12 |
3 |
p. 282-
1 p.
|
artikel
|
| 12 |
A case of synchronous quadruple lung cancer
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 13 |
A case of tracheal cancer following completion pneumonectomy for double primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 282-
1 p.
|
artikel
|
| 14 |
A case report of pulmonary squamous cell carcinoma accompanying myasthenia gravis
|
|
|
1995
|
12 |
3 |
p. 285-
1 p.
|
artikel
|
| 15 |
Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice
|
|
|
1995
|
12 |
3 |
p. 306-
1 p.
|
artikel
|
| 16 |
Activation of the protein-tyrosine kinase associated with the bombesin receptor complex in small cell lung carcinomas
|
|
|
1995
|
12 |
3 |
p. 275-
1 p.
|
artikel
|
| 17 |
Adenocarcinoma of the lung with unusual invasion of metastases into the pericardium
|
|
|
1995
|
12 |
3 |
p. 293-
1 p.
|
artikel
|
| 18 |
Adjuvant chemotherapy for non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 323-
1 p.
|
artikel
|
| 19 |
Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer: An LCSG trial
|
|
|
1995
|
12 |
3 |
p. 323-
1 p.
|
artikel
|
| 20 |
Adjuvant immunotherapy with intrapleural streptococcus pyogenes (OK-432) in lung cancer patients after resection
|
|
|
1995
|
12 |
3 |
p. 326-
1 p.
|
artikel
|
| 21 |
Advances in pathobiological research on lung carcinoma
|
|
|
1995
|
12 |
3 |
p. 278-
1 p.
|
artikel
|
| 22 |
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: A regimen associated with major toxicity in patients with advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 305-
1 p.
|
artikel
|
| 23 |
Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancer
|
|
|
1995
|
12 |
3 |
p. 315-
1 p.
|
artikel
|
| 24 |
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 324-
1 p.
|
artikel
|
| 25 |
A mortality study of lung cancer among Swiss professional drivers: Accounting for the smoking related fraction by a multivariate approach
|
|
|
1995
|
12 |
3 |
p. 267-
1 p.
|
artikel
|
| 26 |
Analysis of DNA ploidy with bronchoscopic brushing specimen as a diagnostic aid for lung cancer
|
|
|
1995
|
12 |
3 |
p. 272-
1 p.
|
artikel
|
| 27 |
Analysis of the energy balance in lung cancer patients
|
|
|
1995
|
12 |
3 |
p. 284-
1 p.
|
artikel
|
| 28 |
Anatomic basis of lymphatic spread of lung carcinoma to the mediastinum: Anatomo-clinical correlations
|
|
|
1995
|
12 |
3 |
p. 291-292
2 p.
|
artikel
|
| 29 |
An autopsy case of lung cancer metastasizing to renal cell cancer and rectal villous adenoma
|
|
|
1995
|
12 |
3 |
p. 280-
1 p.
|
artikel
|
| 30 |
A new procedure for right upper lobectomy of lung with recon-struction of the carina
|
|
|
1995
|
12 |
3 |
p. 298-
1 p.
|
artikel
|
| 31 |
An expert system for teaching cytopathologic diagnosis of lung cancers
|
|
|
1995
|
12 |
3 |
p. 279-
1 p.
|
artikel
|
| 32 |
Antitumor activity of combination treatment combining gemcitabine with cisplatin or vindesine against human lung cancer xenografted in nude mice
|
|
|
1995
|
12 |
3 |
p. 308-
1 p.
|
artikel
|
| 33 |
A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: An interim toxicity analysis of the first 100 patients
|
|
|
1995
|
12 |
3 |
p. 320-
1 p.
|
artikel
|
| 34 |
A phase II study of cisplatin, 5-fluorouracil, and leucovorin aug-mented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: Rationale and study design
|
|
|
1995
|
12 |
3 |
p. 311-
1 p.
|
artikel
|
| 35 |
A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 303-
1 p.
|
artikel
|
| 36 |
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 305-
1 p.
|
artikel
|
| 37 |
A phase II study testing weekly platinum derivative combination chemotherapy as second-line treatment in patients with advanced small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 277-
1 p.
|
artikel
|
| 38 |
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor sup-port for advanced malignancies of the chest
|
|
|
1995
|
12 |
3 |
p. 320-321
2 p.
|
artikel
|
| 39 |
A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 323-
1 p.
|
artikel
|
| 40 |
A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung: LCSG protocol 771
|
|
|
1995
|
12 |
3 |
p. 323-324
2 p.
|
artikel
|
| 41 |
Approaches to the analysis of quality of life data: Experiences gained from a medical research council lung cancer working party palliative chemotherapy trial
|
|
|
1995
|
12 |
3 |
p. 308-309
2 p.
|
artikel
|
| 42 |
A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy
|
|
|
1995
|
12 |
3 |
p. 323-
1 p.
|
artikel
|
| 43 |
A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer
|
Erkisi, Melek
|
|
1995
|
12 |
3 |
p. 237-246
10 p.
|
artikel
|
| 44 |
Are pathologists biased by clinical information? A blinded cross-over study of the histopathological diagnosis of mesothelial tumours versus pulmonary adenocarcinoma
|
|
|
1995
|
12 |
3 |
p. 277-
1 p.
|
artikel
|
| 45 |
A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis
|
|
|
1995
|
12 |
3 |
p. 295-
1 p.
|
artikel
|
| 46 |
Assessment of bone marrow involvement by magnetic resonance imaging in small cell lung cancer: No significant change of staging
|
|
|
1995
|
12 |
3 |
p. 295-296
2 p.
|
artikel
|
| 47 |
Association between a cytochrome P450 CYPIA1 genotype and incidence of lung cancer
|
|
|
1995
|
12 |
3 |
p. 283-
1 p.
|
artikel
|
| 48 |
Asthma and lung cancer by diesel exhaust
|
|
|
1995
|
12 |
3 |
p. 268-
1 p.
|
artikel
|
| 49 |
A suspected case of T0N1M0 small cell carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 292-293
2 p.
|
artikel
|
| 50 |
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: An expanded analysis
|
|
|
1995
|
12 |
3 |
p. 312-
1 p.
|
artikel
|
| 51 |
Basic and clinical studies on serum cytokeratin 19 fragment assay using centocorR CYFRA 21-1 kit in patients with lung cancer
|
|
|
1995
|
12 |
3 |
p. 297-
1 p.
|
artikel
|
| 52 |
Bilateral synchronous muscle-sparing thoracotomy in the manage-ment of bilateral pulmonary neoplasms
|
|
|
1995
|
12 |
3 |
p. 300-
1 p.
|
artikel
|
| 53 |
Biologic characterization of pleural metastases from lung adenocarcinoma: Description of the new DV90 cell line
|
|
|
1995
|
12 |
3 |
p. 270-
1 p.
|
artikel
|
| 54 |
Bronchial and thymic carcinoid tumors: A review
|
|
|
1995
|
12 |
3 |
p. 327-
1 p.
|
artikel
|
| 55 |
Bronchial arterial hemodynamics after thoracic irradiation therapy in lung cancer patients
|
|
|
1995
|
12 |
3 |
p. 316-
1 p.
|
artikel
|
| 56 |
Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin
|
|
|
1995
|
12 |
3 |
p. 283-
1 p.
|
artikel
|
| 57 |
Bronchioloalveolar cell carcinoma in solitary pulmonary nodule (SPN) with cavitary lesion
|
|
|
1995
|
12 |
3 |
p. 289-
1 p.
|
artikel
|
| 58 |
Bronchogenic carcinoma in HIV-positive patients: Findings on chest radiographs and CT scans
|
|
|
1995
|
12 |
3 |
p. 285-
1 p.
|
artikel
|
| 59 |
Bronchogenic carcinoma presenting as a pseudopregnancy
|
|
|
1995
|
12 |
3 |
p. 280-
1 p.
|
artikel
|
| 60 |
Bronchogenic carcinoma: Utility of CT in the evaluation of patients with suspected lesions
|
|
|
1995
|
12 |
3 |
p. 289-
1 p.
|
artikel
|
| 61 |
Bronchoplastic procedures for lung cancer: Clinical study in 136 patients
|
|
|
1995
|
12 |
3 |
p. 299-
1 p.
|
artikel
|
| 62 |
Bronchopulmonary precancerous and tumor diseases — Risk groups from the point of view of occupational medicine
|
|
|
1995
|
12 |
3 |
p. 265-266
2 p.
|
artikel
|
| 63 |
BW2258U89: A GRP receptor antagonist which inhibits small cell lung cancer growth
|
|
|
1995
|
12 |
3 |
p. 270-
1 p.
|
artikel
|
| 64 |
Carboplatin and etoposide in extensive small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 307-
1 p.
|
artikel
|
| 65 |
Carboplatin, epirubicin, etoposide and thoracic radiotherapy in the treatment of localized small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 320-
1 p.
|
artikel
|
| 66 |
Carboplatin plus oral etoposide in elderly patients with non small cell lung cancer. A study of the ‘Groupe francais de pneumocancerologie’ (GFPC)
|
|
|
1995
|
12 |
3 |
p. 305-306
2 p.
|
artikel
|
| 67 |
Carcinoid tumors of the lung: do atypical features require aggressive management?
|
|
|
1995
|
12 |
3 |
p. 281-
1 p.
|
artikel
|
| 68 |
Case report; metastasis of lung adenocarcinoma simulating a falx meningioma
|
|
|
1995
|
12 |
3 |
p. 289-
1 p.
|
artikel
|
| 69 |
Cell type-specific regulation of p53 expression in non-small cell lung carcinoma cells
|
|
|
1995
|
12 |
3 |
p. 270-271
2 p.
|
artikel
|
| 70 |
Changes in plasma TGFB levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis
|
|
|
1995
|
12 |
3 |
p. 319-
1 p.
|
artikel
|
| 71 |
Chemotherapy in small cell lung carcinoma. Prognostic value of complete response in 12800 patients
|
|
|
1995
|
12 |
3 |
p. 302-
1 p.
|
artikel
|
| 72 |
Cholecystokinin-B/gastrin receptor: A novel molecular probe for human small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 270-
1 p.
|
artikel
|
| 73 |
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: A randomised study
|
|
|
1995
|
12 |
3 |
p. 314-
1 p.
|
artikel
|
| 74 |
Clarithromycin in the long-term treatment of primary lung cancer. Possibility of clarithromycin as a biological response modifier
|
|
|
1995
|
12 |
3 |
p. 325-
1 p.
|
artikel
|
| 75 |
Clinical assessment of postoperative immunochemotherapy for non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 324-
1 p.
|
artikel
|
| 76 |
Clinical evaluation of serum tissue polypeptidespecific antigen (TPS) in non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 287-
1 p.
|
artikel
|
| 77 |
Clinical significance of S-phase fraction in small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 289-
1 p.
|
artikel
|
| 78 |
Clinical study of primary lung cancer with sarcomatous components
|
|
|
1995
|
12 |
3 |
p. 276-
1 p.
|
artikel
|
| 79 |
Clinicopathological characteristics of tumor doubling time in primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 291-
1 p.
|
artikel
|
| 80 |
Clinicopathologic features of small cell lung cancer presenting as a solitary pulmonary nodule
|
|
|
1995
|
12 |
3 |
p. 291-
1 p.
|
artikel
|
| 81 |
Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs
|
|
|
1995
|
12 |
3 |
p. 275-
1 p.
|
artikel
|
| 82 |
Coaching persons with lung cancer to report sensory pain: Literature review and pilot study findings
|
|
|
1995
|
12 |
3 |
p. 281-
1 p.
|
artikel
|
| 83 |
Cognitive deficits in patients with small cell lung cancer before and after chemotherapy
|
Meyers, Christina A.
|
|
1995
|
12 |
3 |
p. 231-235
5 p.
|
artikel
|
| 84 |
Co-localization of three neuropeptides and NADPH diaphorase in a small cell lung carcinoma cell line
|
|
|
1995
|
12 |
3 |
p. 273-
1 p.
|
artikel
|
| 85 |
Combination of cisplatin and interferon-α2a (RoferonR-A) in patients with non-small cell lung cancer (NSCLC). An open phase II multicentre study
|
|
|
1995
|
12 |
3 |
p. 303-
1 p.
|
artikel
|
| 86 |
Combined chemotherapy and radiotherapy: From biology to bed-side
|
|
|
1995
|
12 |
3 |
p. 321-
1 p.
|
artikel
|
| 87 |
Combined-modality treatment of small-cell lung cancer: Randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest
|
|
|
1995
|
12 |
3 |
p. 321-
1 p.
|
artikel
|
| 88 |
Combined multimodality treatment for non-small cell lung cancer-With special reference to pre- and post-operative adjuvant therapy
|
|
|
1995
|
12 |
3 |
p. 322-
1 p.
|
artikel
|
| 89 |
Combined thoracoscopy and mediastinoscopy for the evaluation of mediastinal lymph node metastasis in left upper lobe lung cancer
|
|
|
1995
|
12 |
3 |
p. 297-
1 p.
|
artikel
|
| 90 |
Comparative activity of navelbine, navelbine + cisplatin, and vin-desine + cisplatin in the therapy of unresectable non small cell lung carcinoma. Results of a multicentric European randomized trial including 612 patients
|
|
|
1995
|
12 |
3 |
p. 307-
1 p.
|
artikel
|
| 91 |
Comparative assessment of three radiotherapy treatment protocols for inoperable cerebral metastases of non-small cell lung carcinoma
|
|
|
1995
|
12 |
3 |
p. 317-
1 p.
|
artikel
|
| 92 |
Comparative evaluation of relative survival versus classical methods applied to patients with non small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 300-
1 p.
|
artikel
|
| 93 |
Comparison of autopsy, clinical and death certificate diagnosis with particular reference to lung cancer. A review of the published data
|
|
|
1995
|
12 |
3 |
p. 278-
1 p.
|
artikel
|
| 94 |
Comparison of effect of I.V.cisplatin (DDP) with I.V.carboplatin (CDP) in the treatment of advanced lung cancer under maximum tolerance dosages (MTD)
|
|
|
1995
|
12 |
3 |
p. 315-
1 p.
|
artikel
|
| 95 |
Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells
|
|
|
1995
|
12 |
3 |
p. 317-
1 p.
|
artikel
|
| 96 |
Concomitant administration of interleukin-2 plus tumor necrosis factor in advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 303-
1 p.
|
artikel
|
| 97 |
Concurrent chemo-radiotherapy for stage III non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 320-
1 p.
|
artikel
|
| 98 |
Concurrent chemotherapy (CT) and radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC): A review
|
|
|
1995
|
12 |
3 |
p. 321-
1 p.
|
artikel
|
| 99 |
Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell lines
|
|
|
1995
|
12 |
3 |
p. 270-
1 p.
|
artikel
|
| 100 |
Correlation of p53 protein overexpression, gene mutation with prognosis in resected non-small cell lung cancer (NSCLC) patients
|
|
|
1995
|
12 |
3 |
p. 272-
1 p.
|
artikel
|
| 101 |
Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 296-
1 p.
|
artikel
|
| 102 |
CT demonstration of calcification in carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 292-
1 p.
|
artikel
|
| 103 |
CT scanning of bronchioloalveolar carcinoma: specific appearances
|
Akata, Soichi
|
|
1995
|
12 |
3 |
p. 221-230
10 p.
|
artikel
|
| 104 |
Current management of unresectable non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 328-
1 p.
|
artikel
|
| 105 |
Current status of neoadjuvant therapy for non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 322-
1 p.
|
artikel
|
| 106 |
Current status of surgical resection for lung cancer
|
|
|
1995
|
12 |
3 |
p. 299-
1 p.
|
artikel
|
| 107 |
Current treatment of forms of small-cell bronchial carcinoma limited to the hemithorax
|
|
|
1995
|
12 |
3 |
p. 320-
1 p.
|
artikel
|
| 108 |
Cyclocreatine in cancer chemotherapy
|
|
|
1995
|
12 |
3 |
p. 304-
1 p.
|
artikel
|
| 109 |
CYFRA 21-1: A new tumor marker for lung cancer?
|
|
|
1995
|
12 |
3 |
p. 284-
1 p.
|
artikel
|
| 110 |
CYFRA 21-1: Preliminary experiences in bronchial carcinoma and other tumors
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 111 |
Cytochemical studies to determine the histogenesis in anaplastic or poorly differentiated pulmonary tumours
|
|
|
1995
|
12 |
3 |
p. 280-
1 p.
|
artikel
|
| 112 |
Cytogenetic analysis of 63 non-small cell lung carcinomas: Recurrent chromosoma alterations amid frequent and widespread genomic upheaval
|
|
|
1995
|
12 |
3 |
p. 274-
1 p.
|
artikel
|
| 113 |
Cytologic characterization of bronchial epithelial changes in small cell carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 276-
1 p.
|
artikel
|
| 114 |
Cytologic features of peripheral squamous cell carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 276-
1 p.
|
artikel
|
| 115 |
Cytotoxic effect of herbal medicine Sho-saiko-to on human lung cancer cell lines in vitro
|
|
|
1995
|
12 |
3 |
p. 306-
1 p.
|
artikel
|
| 116 |
Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase II Southwest Oncology Group study
|
|
|
1995
|
12 |
3 |
p. 324-
1 p.
|
artikel
|
| 117 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro
|
|
|
1995
|
12 |
3 |
p. 316-
1 p.
|
artikel
|
| 118 |
Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells
|
|
|
1995
|
12 |
3 |
p. 313-
1 p.
|
artikel
|
| 119 |
Deposition and retention of inhaled fibres: Effects on incidence of lung cancer and mesothelioma
|
|
|
1995
|
12 |
3 |
p. 267-268
2 p.
|
artikel
|
| 120 |
Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations
|
|
|
1995
|
12 |
3 |
p. 282-
1 p.
|
artikel
|
| 121 |
Detection of c-myc and c-sis mRNA in human non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 269-270
2 p.
|
artikel
|
| 122 |
Detection of intratumoral DNA heterogeneity in primary lung cancer using a multiple sampling method
|
|
|
1995
|
12 |
3 |
p. 272-
1 p.
|
artikel
|
| 123 |
Diagnosis of mediastinal lymph node metastasis from primary lung cancer on MR imaging with the STIR technique-Reevaluation of usefulness: Comparison with CT, conventional MRI and MRI with the STIR technique
|
|
|
1995
|
12 |
3 |
p. 291-
1 p.
|
artikel
|
| 124 |
Diagnostic yield of transthoracic needle aspiration biopsy following negative fiberoptic bronchoscopy in 103 patients with peripheral circumscribed pulmonary lesions
|
|
|
1995
|
12 |
3 |
p. 283-
1 p.
|
artikel
|
| 125 |
Dietary cholesterol, fat, and lung cancer incidence among older women: The Iowa Women's Health Study (United States)
|
|
|
1995
|
12 |
3 |
p. 268-269
2 p.
|
artikel
|
| 126 |
Differentiation of adenocarcinoma of the lung and malignant mesothelioma: Predictive value and reproducibility of immunoreactive antibodies
|
|
|
1995
|
12 |
3 |
p. 279-
1 p.
|
artikel
|
| 127 |
Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients
|
|
|
1995
|
12 |
3 |
p. 267-
1 p.
|
artikel
|
| 128 |
Diffuse infiltrating pulmonary neoplasm with an analysis of 43 cases
|
|
|
1995
|
12 |
3 |
p. 292-
1 p.
|
artikel
|
| 129 |
Distribution pattern of the basement membrane components is one of the significant prognostic correlates in peripheral lung adenocarcinomas
|
|
|
1995
|
12 |
3 |
p. 276-
1 p.
|
artikel
|
| 130 |
Dose-finding study of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 315-
1 p.
|
artikel
|
| 131 |
Dose intensity of the CAVE regimen in small cell lung cancer correlates to response rate
|
|
|
1995
|
12 |
3 |
p. 305-
1 p.
|
artikel
|
| 132 |
Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 312-
1 p.
|
artikel
|
| 133 |
DT-diaphorase as a determinant of sensitivity to adriamycin in non-small-cell lung-cancer cell lines
|
|
|
1995
|
12 |
3 |
p. 313-
1 p.
|
artikel
|
| 134 |
Early and long-term results after completion pneumonectomy
|
|
|
1995
|
12 |
3 |
p. 297-
1 p.
|
artikel
|
| 135 |
Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer
|
|
|
1995
|
12 |
3 |
p. 308-
1 p.
|
artikel
|
| 136 |
Effect of coenzyme Q10 and azelastin on protecting radiation pneumonitis with lung cancer
|
|
|
1995
|
12 |
3 |
p. 304-
1 p.
|
artikel
|
| 137 |
Effect of superoxide dismutase and diethyldithiocarbamate on the induction of squamous cell carcinoma of lung with methylcholanthrene in rats
|
|
|
1995
|
12 |
3 |
p. 268-
1 p.
|
artikel
|
| 138 |
Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung: LCSG 773
|
|
|
1995
|
12 |
3 |
p. 323-
1 p.
|
artikel
|
| 139 |
Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice
|
|
|
1995
|
12 |
3 |
p. 314-315
2 p.
|
artikel
|
| 140 |
Efficacy of combination multidrug chemotherapy (mitomycin, ifosfamide and cisplatin) and radiotherapy for treatment of brain metastases in non small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 306-
1 p.
|
artikel
|
| 141 |
Endoscopic criteria of early squamous cell carcinoma of the bronchus
|
|
|
1995
|
12 |
3 |
p. 287-
1 p.
|
artikel
|
| 142 |
Establishment of a human small-cell lung-cancer subline resistant to okadaic acid
|
|
|
1995
|
12 |
3 |
p. 316-
1 p.
|
artikel
|
| 143 |
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells
|
|
|
1995
|
12 |
3 |
p. 314-
1 p.
|
artikel
|
| 144 |
Evaluation of a decision-support system for inoperable non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 329-
1 p.
|
artikel
|
| 145 |
Evaluation of intrapulmonary nodules by positron emission tomo-graphy
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 146 |
Evaluation of prognostic significance of p53 gene alterations in patients with surgically resected lung cancer
|
|
|
1995
|
12 |
3 |
p. 298-
1 p.
|
artikel
|
| 147 |
Evaluation of the therapeutic prognosis and long-term survivors of small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 327-
1 p.
|
artikel
|
| 148 |
Evolution of aerodigestive tract 13-cis-retinoid acid chemoprevention: The M.D. Anderson experience
|
|
|
1995
|
12 |
3 |
p. 265-
1 p.
|
artikel
|
| 149 |
Exposure to environmental tobacco smoke and risk of lung cancer: The epidemiological evidence
|
|
|
1995
|
12 |
3 |
p. 266-
1 p.
|
artikel
|
| 150 |
Expression of NSE and PGP 9.5 in non-small cell lung cancers
|
|
|
1995
|
12 |
3 |
p. 271-
1 p.
|
artikel
|
| 151 |
Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation
|
|
|
1995
|
12 |
3 |
p. 309-
1 p.
|
artikel
|
| 152 |
Extrapulmonary small cell carcinoma: A single-institution experience and review of the literature
|
|
|
1995
|
12 |
3 |
p. 327-
1 p.
|
artikel
|
| 153 |
Features and significance of nonbacterial thrombotic endocarditis in patients with lung cancer
|
|
|
1995
|
12 |
3 |
p. 291-
1 p.
|
artikel
|
| 154 |
Fiberscopic diagnosis in lung cancer. A report of 45 cases
|
|
|
1995
|
12 |
3 |
p. 296-
1 p.
|
artikel
|
| 155 |
Fluoroscopically guided fine needle pulmonary biopsy using the ROTEX needle: Results from 890 patients with focal lung lesions
|
|
|
1995
|
12 |
3 |
p. 286-
1 p.
|
artikel
|
| 156 |
Future directions in clinical research for lung cancer
|
|
|
1995
|
12 |
3 |
p. 327-
1 p.
|
artikel
|
| 157 |
Gastrointestinal metastases from lung cancer: Report of a case
|
|
|
1995
|
12 |
3 |
p. 295-
1 p.
|
artikel
|
| 158 |
Gene expression of somatostatin receptor sybtypes, SSTR1 and SSTR2, in human lung cancer cell lines
|
|
|
1995
|
12 |
3 |
p. 310-
1 p.
|
artikel
|
| 159 |
General principles of surgery quality control
|
|
|
1995
|
12 |
3 |
p. 299-
1 p.
|
artikel
|
| 160 |
Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene
|
|
|
1995
|
12 |
3 |
p. 326-
1 p.
|
artikel
|
| 161 |
Genetic alterations in p53 and K-Pas in lung cancer in relation to histopathology of the turner and smoking history of the patient
|
|
|
1995
|
12 |
3 |
p. 274-
1 p.
|
artikel
|
| 162 |
Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: A study on host factors in relation to age at onset, gender and histological cancer types
|
|
|
1995
|
12 |
3 |
p. 276-
1 p.
|
artikel
|
| 163 |
Gingival metastasis as first sign of an undifferentiated carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 289-
1 p.
|
artikel
|
| 164 |
High dose rate intraluminal radiotherapy for carcinoma of the bronchus: Outcome of treatment of 406 patients
|
|
|
1995
|
12 |
3 |
p. 318-
1 p.
|
artikel
|
| 165 |
Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression
|
|
|
1995
|
12 |
3 |
p. 275-
1 p.
|
artikel
|
| 166 |
Human papillomavirus type 18 DNA and E6–E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 269-
1 p.
|
artikel
|
| 167 |
Human small cell lung cancer cells express high affinity naloxone-insensitive [125I]β-endorphin binding sites
|
|
|
1995
|
12 |
3 |
p. 270-
1 p.
|
artikel
|
| 168 |
Hyperfractionated irradiation for non-small cell lung cancer (NSCLC)-A phase II clinical trial
|
|
|
1995
|
12 |
3 |
p. 318-
1 p.
|
artikel
|
| 169 |
IASLC calendar
|
|
|
1995
|
12 |
3 |
p. 263-264
2 p.
|
artikel
|
| 170 |
Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue
|
|
|
1995
|
12 |
3 |
p. 275-
1 p.
|
artikel
|
| 171 |
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 279-
1 p.
|
artikel
|
| 172 |
Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas: An immunohistochemical study with ultrastructural correlations
|
|
|
1995
|
12 |
3 |
p. 277-
1 p.
|
artikel
|
| 173 |
Impact of neuroendocrine differentiation in non-small cell lung cancer: The LCSG experience
|
|
|
1995
|
12 |
3 |
p. 278-
1 p.
|
artikel
|
| 174 |
Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer
|
|
|
1995
|
12 |
3 |
p. 281-
1 p.
|
artikel
|
| 175 |
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
|
|
|
1995
|
12 |
3 |
p. 297-298
2 p.
|
artikel
|
| 176 |
Increased radioresistance of an in vitro transformed human small cell lung cancer cell line
|
Brodin, O.
|
|
1995
|
12 |
3 |
p. 183-198
16 p.
|
artikel
|
| 177 |
Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma
|
|
|
1995
|
12 |
3 |
p. 287-288
2 p.
|
artikel
|
| 178 |
Inhalation therapy of interferon-gamma against bronchoalveolar carcinoma of the lung; a case report
|
|
|
1995
|
12 |
3 |
p. 326-
1 p.
|
artikel
|
| 179 |
Inhaled recombinant interferon gamma in patients with lung cancer: Pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and mono-cytes
|
|
|
1995
|
12 |
3 |
p. 307-
1 p.
|
artikel
|
| 180 |
Integrated optical density (IOD), syntactic structure analysis, and survival in operated lung carcinoma patients
|
|
|
1995
|
12 |
3 |
p. 267-
1 p.
|
artikel
|
| 181 |
International survey of radiotherapy practice for radical treatment of non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 317-
1 p.
|
artikel
|
| 182 |
Interobserver variation in the computed tomographic evaluation of mediastinallymph node size in patients with potentially resectable lung cancer
|
|
|
1995
|
12 |
3 |
p. 283-
1 p.
|
artikel
|
| 183 |
Inter-relationships between single carbon units' metabolism and resting energy expenditure in weight-losing patients with small cell lung cancer: Effects of methionine supply and chemotherapy
|
|
|
1995
|
12 |
3 |
p. 289-
1 p.
|
artikel
|
| 184 |
Intraluminal irradiation in the treatment of malignant airway obstruction
|
|
|
1995
|
12 |
3 |
p. 317-
1 p.
|
artikel
|
| 185 |
In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice
|
|
|
1995
|
12 |
3 |
p. 307-
1 p.
|
artikel
|
| 186 |
Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
|
|
|
1995
|
12 |
3 |
p. 302-
1 p.
|
artikel
|
| 187 |
Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production
|
|
|
1995
|
12 |
3 |
p. 284-
1 p.
|
artikel
|
| 188 |
K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas
|
|
|
1995
|
12 |
3 |
p. 271-
1 p.
|
artikel
|
| 189 |
Lack of tissue specificity of mucin markers in a lung cancer model: Biochemical approach
|
|
|
1995
|
12 |
3 |
p. 272-
1 p.
|
artikel
|
| 190 |
Late phase II clinical study of KW-2307 in previously untreated patients with non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 316-
1 p.
|
artikel
|
| 191 |
Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 308-
1 p.
|
artikel
|
| 192 |
Lipid pneumonia and associated bronchio-alveolar carcinoma
|
|
|
1995
|
12 |
3 |
p. 284-
1 p.
|
artikel
|
| 193 |
Long-term antimicrobial prophylaxis in lung cancer surgery: Correlation between microbiological findings and empyema development
|
|
|
1995
|
12 |
3 |
p. 298-
1 p.
|
artikel
|
| 194 |
Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 313-
1 p.
|
artikel
|
| 195 |
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 315-
1 p.
|
artikel
|
| 196 |
Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas
|
|
|
1995
|
12 |
3 |
p. 275-
1 p.
|
artikel
|
| 197 |
Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer
|
|
|
1995
|
12 |
3 |
p. 271-
1 p.
|
artikel
|
| 198 |
Low-dose chemotherapy delays relapse of a dominated and resistant sub-population in a heterogeneous human SCLC xenograft in nude mice
|
|
|
1995
|
12 |
3 |
p. 314-
1 p.
|
artikel
|
| 199 |
Lung adenocarcinoma and indicators of asbestos exposure
|
|
|
1995
|
12 |
3 |
p. 266-
1 p.
|
artikel
|
| 200 |
Lung adenocarcinoma and metastasis in cavernous bodies of the penis
|
|
|
1995
|
12 |
3 |
p. 296-
1 p.
|
artikel
|
| 201 |
Lung cancer
|
|
|
1995
|
12 |
3 |
p. 326-327
2 p.
|
artikel
|
| 202 |
Lung cancer and cigarette smoking in women: A case-control study in Barcelona (Spain)
|
|
|
1995
|
12 |
3 |
p. 268-
1 p.
|
artikel
|
| 203 |
Lung cancer and tobacco smoking
|
Boyle, Peter
|
|
1995
|
12 |
3 |
p. 167-181
15 p.
|
artikel
|
| 204 |
Lung cancer incidence after exposure of rats to low doses of radon: Influence of dose rate
|
|
|
1995
|
12 |
3 |
p. 267-
1 p.
|
artikel
|
| 205 |
Lung cancer in Estonia in 1968–1987: Time trends and public health implications
|
|
|
1995
|
12 |
3 |
p. 269-
1 p.
|
artikel
|
| 206 |
Lung cancer mortality in a French cohort of hard-metal workers
|
|
|
1995
|
12 |
3 |
p. 268-
1 p.
|
artikel
|
| 207 |
Lung cancer pathology in smokers, ex-smokers and never smokers
|
|
|
1995
|
12 |
3 |
p. 277-
1 p.
|
artikel
|
| 208 |
Lung cancer surgery: A critical review of the evidence
|
|
|
1995
|
12 |
3 |
p. 300-
1 p.
|
artikel
|
| 209 |
Lung cancer with skin metastasis
|
|
|
1995
|
12 |
3 |
p. 292-
1 p.
|
artikel
|
| 210 |
Lung tumor induction in A/J mice and clastogenic effects in CD-1 mice of the sequence-selective DNA alkylating agents (+)-CC-1065 and (−)-CC-1065
|
|
|
1995
|
12 |
3 |
p. 269-
1 p.
|
artikel
|
| 211 |
Management of regionally advanced (stage III) non-small cell lung cancer: LCSG 831
|
|
|
1995
|
12 |
3 |
p. 299-
1 p.
|
artikel
|
| 212 |
Measurable or assessable disease in lung cancer trials: Does it matter?
|
|
|
1995
|
12 |
3 |
p. 286-
1 p.
|
artikel
|
| 213 |
Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay
|
|
|
1995
|
12 |
3 |
p. 284-
1 p.
|
artikel
|
| 214 |
Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 285-
1 p.
|
artikel
|
| 215 |
Metastasis in tongue from carcinoma of bronchus: A case report
|
|
|
1995
|
12 |
3 |
p. 286-
1 p.
|
artikel
|
| 216 |
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: A FONICAP randomised phase II study
|
|
|
1995
|
12 |
3 |
p. 306-
1 p.
|
artikel
|
| 217 |
Molecular pathogenesis of lung cancer: Implications for early diagnosis by new screening tests
|
|
|
1995
|
12 |
3 |
p. 271-
1 p.
|
artikel
|
| 218 |
Mortality of iron foundry workers. III. Lung cancer case-control study
|
|
|
1995
|
12 |
3 |
p. 267-
1 p.
|
artikel
|
| 219 |
MR imaging of bronchogenic carcinoma
|
|
|
1995
|
12 |
3 |
p. 284-
1 p.
|
artikel
|
| 220 |
Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinoma
|
|
|
1995
|
12 |
3 |
p. 292-
1 p.
|
artikel
|
| 221 |
NDPK/nm23 expression and its correlation with lymph node metastasis in human lung cancer
|
|
|
1995
|
12 |
3 |
p. 290-
1 p.
|
artikel
|
| 222 |
New promising anticancer drugs for lung cancer
|
|
|
1995
|
12 |
3 |
p. 308-
1 p.
|
artikel
|
| 223 |
Nulear magnetic resonance relaxation times for human lung cancer and lung tissues
|
|
|
1995
|
12 |
3 |
p. 269-
1 p.
|
artikel
|
| 224 |
One hundred and one cases of bronchoplasty for primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 299-
1 p.
|
artikel
|
| 225 |
Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: A preliminary report
|
|
|
1995
|
12 |
3 |
p. 312-
1 p.
|
artikel
|
| 226 |
Palliative endobronchial brachytherapy for central lung tumors: A prospective, randomized comparison of two fractionation schedules
|
|
|
1995
|
12 |
3 |
p. 317-
1 p.
|
artikel
|
| 227 |
Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer
|
|
|
1995
|
12 |
3 |
p. 309-
1 p.
|
artikel
|
| 228 |
Passive smoking in the workplace: Classical and Bayesian metaanalyses
|
|
|
1995
|
12 |
3 |
p. 266-
1 p.
|
artikel
|
| 229 |
Pathology of the pulmonary arteries in malignant neoplasms of the lung
|
|
|
1995
|
12 |
3 |
p. 279-
1 p.
|
artikel
|
| 230 |
Patterns of p53 mutations in squamous cell carcinoma of the lung: Acquisition at a relatively early age
|
|
|
1995
|
12 |
3 |
p. 271-
1 p.
|
artikel
|
| 231 |
Percutaneous balloon pericardiotomy for management of cardiac tamponade in a patient with lung cancer and large pericardial effusion
|
|
|
1995
|
12 |
3 |
p. 281-282
2 p.
|
artikel
|
| 232 |
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer
|
|
|
1995
|
12 |
3 |
p. 310-
1 p.
|
artikel
|
| 233 |
Phase II clinical trial of didemnin B in previously treated small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 308-
1 p.
|
artikel
|
| 234 |
Phase I II study of a combination regimen composed of cisplatin, carboplatin and etoposide against small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 306-
1 p.
|
artikel
|
| 235 |
Phase III trial of recombinant interferon gamma in complete responders with Small-Cell Lung Cancer
|
|
|
1995
|
12 |
3 |
p. 313-
1 p.
|
artikel
|
| 236 |
Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 311-
1 p.
|
artikel
|
| 237 |
Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 325-
1 p.
|
artikel
|
| 238 |
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 301-302
2 p.
|
artikel
|
| 239 |
Phase II trial of carboplatin in combination with etoposide in locally advanced large cell carcinoma and adenocarcinoma of the lung
|
Fuentes, Rafael
|
|
1995
|
12 |
3 |
p. 259-262
4 p.
|
artikel
|
| 240 |
Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer
|
Jacoulet, Pascale
|
|
1995
|
12 |
3 |
p. 247-257
11 p.
|
artikel
|
| 241 |
Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 321-
1 p.
|
artikel
|
| 242 |
Phase 2 study of prolonged administration of oral etoposide in combination with weekly cisplatin in advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 316-317
2 p.
|
artikel
|
| 243 |
Photodynamic therapy of lung cancer
|
|
|
1995
|
12 |
3 |
p. 325-
1 p.
|
artikel
|
| 244 |
p53 Immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer: A preliminary report of LCSG 871
|
|
|
1995
|
12 |
3 |
p. 288-
1 p.
|
artikel
|
| 245 |
Plasma 5-fluorouracil and α-fluoro-β-alanin accumulation in lung cabcer patients treated with continuous infusion of cisplatin and 5-fluorouracil
|
|
|
1995
|
12 |
3 |
p. 309-
1 p.
|
artikel
|
| 246 |
Pneumonectomy after contralateral lobectomy: Is it reasonable?
|
|
|
1995
|
12 |
3 |
p. 297-
1 p.
|
artikel
|
| 247 |
Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose
|
|
|
1995
|
12 |
3 |
p. 294-
1 p.
|
artikel
|
| 248 |
Postoperative radiation for lung cancer metastatic to the brain
|
|
|
1995
|
12 |
3 |
p. 318-
1 p.
|
artikel
|
| 249 |
Potentiation of growth inhibition due to vincristine by ascorbic acid in a resistant human non-small cell lung cancer cell line
|
|
|
1995
|
12 |
3 |
p. 304-
1 p.
|
artikel
|
| 250 |
Practical approaches to the treatment of patients with extensive stage small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 328-
1 p.
|
artikel
|
| 251 |
Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging
|
|
|
1995
|
12 |
3 |
p. 287-
1 p.
|
artikel
|
| 252 |
Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: A European cancer centre effort
|
|
|
1995
|
12 |
3 |
p. 315-
1 p.
|
artikel
|
| 253 |
Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 294-
1 p.
|
artikel
|
| 254 |
Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer: A phase 2 study of the LCSG
|
|
|
1995
|
12 |
3 |
p. 322-
1 p.
|
artikel
|
| 255 |
Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study
|
|
|
1995
|
12 |
3 |
p. 325-
1 p.
|
artikel
|
| 256 |
Preoperative evaluation of stage I and stage II non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 286-287
2 p.
|
artikel
|
| 257 |
Preoperative risk evaluation for lung cancer resection: Predicted postoperative product as a predictor of surgical mortality
|
|
|
1995
|
12 |
3 |
p. 301-
1 p.
|
artikel
|
| 258 |
Preoperative staging of carcinoma of the bronchus: Can computed tomographic scanning reliably identify stage III tumours?
|
|
|
1995
|
12 |
3 |
p. 295-
1 p.
|
artikel
|
| 259 |
Primary carcinoids of the lungs-Asbestos dust-induced malignancies in the sense of occupational disease no. 4104 BeKV?
|
|
|
1995
|
12 |
3 |
p. 268-
1 p.
|
artikel
|
| 260 |
Prognostic factors of primary lung cancer. Assessment of tumor doubling time in survival
|
|
|
1995
|
12 |
3 |
p. 282-
1 p.
|
artikel
|
| 261 |
Prognostic importance of human papilloma virus typing in squamous cell papilloma of the bronchus: Comparison of in situ hybridization and the polymerase chain reaction
|
|
|
1995
|
12 |
3 |
p. 292-
1 p.
|
artikel
|
| 262 |
Prognostic significance of an interface pattern of central fibrosis and tumor cells in peripheral adenocarcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 277-
1 p.
|
artikel
|
| 263 |
Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection
|
|
|
1995
|
12 |
3 |
p. 298-
1 p.
|
artikel
|
| 264 |
Prognostic significance of tissue polypeptidespecific antigen (TPS) in patients with advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 287-
1 p.
|
artikel
|
| 265 |
Prognostic value of a 90kD subunit containing glycoprotein tumor-associated antigen specific immune complexes in lung cancer patients
|
|
|
1995
|
12 |
3 |
p. 295-
1 p.
|
artikel
|
| 266 |
Proliferating cell nuclear antigen and Ki-67 in lung carcinoma: Correlation with DNA flow cytometric analysis
|
|
|
1995
|
12 |
3 |
p. 274-
1 p.
|
artikel
|
| 267 |
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: Analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases
|
|
|
1995
|
12 |
3 |
p. 318-319
2 p.
|
artikel
|
| 268 |
Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer
|
|
|
1995
|
12 |
3 |
p. 299-
1 p.
|
artikel
|
| 269 |
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensivestage small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 309-
1 p.
|
artikel
|
| 270 |
Prostatic metastasis of a small cell lung cancer in a young male
|
|
|
1995
|
12 |
3 |
p. 295-
1 p.
|
artikel
|
| 271 |
Pulmonary blastomas. Report on two cases and litrature review
|
|
|
1995
|
12 |
3 |
p. 278-
1 p.
|
artikel
|
| 272 |
Pulmonary carcinoma metastatic to the larynx
|
|
|
1995
|
12 |
3 |
p. 293-
1 p.
|
artikel
|
| 273 |
Quality-of-life following thoracotomy for lung cancer
|
|
|
1995
|
12 |
3 |
p. 298-
1 p.
|
artikel
|
| 274 |
Quality of life in lung cancer surgical adjuvant trials
|
|
|
1995
|
12 |
3 |
p. 299-
1 p.
|
artikel
|
| 275 |
Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B
|
|
|
1995
|
12 |
3 |
p. 324-
1 p.
|
artikel
|
| 276 |
Quality of life in patients with lung cancer
|
|
|
1995
|
12 |
3 |
p. 328-
1 p.
|
artikel
|
| 277 |
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine
|
|
|
1995
|
12 |
3 |
p. 303-304
2 p.
|
artikel
|
| 278 |
Radiation thrapy for irresectable non-small-cell lung cancer Preliminary results of a randomized study
|
|
|
1995
|
12 |
3 |
p. 318-
1 p.
|
artikel
|
| 279 |
Radical radiotherapy for early nonsmall cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 302-
1 p.
|
artikel
|
| 280 |
Radiographic abnormalities and the risk of lung cancer among workers exposed to silica dust in Ontario
|
|
|
1995
|
12 |
3 |
p. 265-
1 p.
|
artikel
|
| 281 |
Radiotherapy planning for lung cancer: Can we do better?
|
|
|
1995
|
12 |
3 |
p. 319-
1 p.
|
artikel
|
| 282 |
Radon and primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 266-
1 p.
|
artikel
|
| 283 |
Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung: LCSG 881
|
|
|
1995
|
12 |
3 |
p. 322-
1 p.
|
artikel
|
| 284 |
Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: A cancer research campaign trial
|
|
|
1995
|
12 |
3 |
p. 310-311
2 p.
|
artikel
|
| 285 |
Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 319-320
2 p.
|
artikel
|
| 286 |
Recent change of management in advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 327-
1 p.
|
artikel
|
| 287 |
Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines
|
|
|
1995
|
12 |
3 |
p. 306-
1 p.
|
artikel
|
| 288 |
Re-evaluation of bronchogenic carcinoma after X-ray and chemo-therapy. The role of CT and MRI
|
|
|
1995
|
12 |
3 |
p. 324-
1 p.
|
artikel
|
| 289 |
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
|
Cella, David F.
|
|
1995
|
12 |
3 |
p. 199-220
22 p.
|
artikel
|
| 290 |
Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption
|
|
|
1995
|
12 |
3 |
p. 301-
1 p.
|
artikel
|
| 291 |
Response rate of small cell lung cancer treated with CE-CAP alternating chemotherapy
|
|
|
1995
|
12 |
3 |
p. 310-
1 p.
|
artikel
|
| 292 |
Results of a clinical multicentric randomized phase II study of non-small cell lung cancer treated with vinorelbine-cisplatin versus vinorelbine alone
|
|
|
1995
|
12 |
3 |
p. 307-
1 p.
|
artikel
|
| 293 |
Retinoblastoma protein expression in lung cancer: An immunohistochemical analysis
|
|
|
1995
|
12 |
3 |
p. 273-
1 p.
|
artikel
|
| 294 |
Retinoblastoma protein in non-small cell lung carcinoma, cells arrested for growth by retinoic acid
|
|
|
1995
|
12 |
3 |
p. 273-
1 p.
|
artikel
|
| 295 |
Risk of lung cancer among cigarette smokers in relation to tumor location
|
|
|
1995
|
12 |
3 |
p. 266-
1 p.
|
artikel
|
| 296 |
Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years
|
|
|
1995
|
12 |
3 |
p. 285-
1 p.
|
artikel
|
| 297 |
Role of determination of serum zinc, copper, and copper/zinc ratio in evaluating diagnosis, therapeutic effect and prognosis of lung cancer
|
|
|
1995
|
12 |
3 |
p. 296-
1 p.
|
artikel
|
| 298 |
Role of mdr1 and p53 expression in the chemoresistance of lung carcinomas
|
|
|
1995
|
12 |
3 |
p. 305-
1 p.
|
artikel
|
| 299 |
Role of mediastinal staging of lung cancer
|
|
|
1995
|
12 |
3 |
p. 288-
1 p.
|
artikel
|
| 300 |
Selective embolization of bronchial artery with drug gelfoam in treatment of lung cancer
|
|
|
1995
|
12 |
3 |
p. 326-
1 p.
|
artikel
|
| 301 |
Serological tumor markers for small cell lung cancer and their therapeutic implications
|
|
|
1995
|
12 |
3 |
p. 294-
1 p.
|
artikel
|
| 302 |
Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer
|
|
|
1995
|
12 |
3 |
p. 281-
1 p.
|
artikel
|
| 303 |
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC)
|
|
|
1995
|
12 |
3 |
p. 296-
1 p.
|
artikel
|
| 304 |
Should we reestablish the lung cancer study group?
|
|
|
1995
|
12 |
3 |
p. 328-329
2 p.
|
artikel
|
| 305 |
Silica dust exposure and lung cancer
|
|
|
1995
|
12 |
3 |
p. 266-267
2 p.
|
artikel
|
| 306 |
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: A phase II study
|
|
|
1995
|
12 |
3 |
p. 310-
1 p.
|
artikel
|
| 307 |
Small cell carcinoma of the lung resembling pleural mesothelioma
|
|
|
1995
|
12 |
3 |
p. 282-
1 p.
|
artikel
|
| 308 |
Small cell lung cancer: Analysis of factors influencing the response to treatment and survival
|
|
|
1995
|
12 |
3 |
p. 328-
1 p.
|
artikel
|
| 309 |
Small cell lung cancer presenting as a metastatic conjunctival tumor
|
|
|
1995
|
12 |
3 |
p. 286-
1 p.
|
artikel
|
| 310 |
Small cell lung cancer (SCLC): A randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as in duction treatment, followed in complete responders by alfa-interferon or no treatment, as maintenance therapy
|
|
|
1995
|
12 |
3 |
p. 302-
1 p.
|
artikel
|
| 311 |
Small cell lung carcinoma in a young patient of only 17 years old. A case report
|
|
|
1995
|
12 |
3 |
p. 283-
1 p.
|
artikel
|
| 312 |
Small giant cell carcinoma of the lung diagnosed preoperatively by transthoracic aspiration cytology: A case report
|
|
|
1995
|
12 |
3 |
p. 282-
1 p.
|
artikel
|
| 313 |
Smoking habits and attitudes of medical students towards smoking and anti-smoking campaigns in the Faculty of Medicine, University of Istanbul, Turkey
|
|
|
1995
|
12 |
3 |
p. 265-
1 p.
|
artikel
|
| 314 |
Solitary pulmonary nodule: Preliminary study of evaluation with incremental dynamic CT
|
|
|
1995
|
12 |
3 |
p. 283-
1 p.
|
artikel
|
| 315 |
Somatostatin receptor expression in lung cancer
|
|
|
1995
|
12 |
3 |
p. 272-273
2 p.
|
artikel
|
| 316 |
Some problems of tracheobronchoplasty for lung cancer in a Regional Hospital in Russia
|
|
|
1995
|
12 |
3 |
p. 297-
1 p.
|
artikel
|
| 317 |
Spontaneous regression of a lung carcinoma. A case report and review of the literature
|
|
|
1995
|
12 |
3 |
p. 282-283
2 p.
|
artikel
|
| 318 |
Squamous cell carcinoma of the lung: Does the nm23 gene expression correlate to the tumor stage?
|
|
|
1995
|
12 |
3 |
p. 293-
1 p.
|
artikel
|
| 319 |
Standard vs. high-dose epirubicin in combination chemotherapy of small cell lung cancer (SCLC)-Results of a phase III randomized trial
|
|
|
1995
|
12 |
3 |
p. 305-
1 p.
|
artikel
|
| 320 |
Stent-implantation for stenotic malignant tracheobronchial tumors
|
|
|
1995
|
12 |
3 |
p. 326-
1 p.
|
artikel
|
| 321 |
Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines
|
|
|
1995
|
12 |
3 |
p. 316-
1 p.
|
artikel
|
| 322 |
Surgery for brain metastases from nonsmall cell lung carcinomas and tissue cultures from the resected specimens
|
|
|
1995
|
12 |
3 |
p. 301-
1 p.
|
artikel
|
| 323 |
Surgery for bronchogenic cancer in patients 75 and over
|
|
|
1995
|
12 |
3 |
p. 301-
1 p.
|
artikel
|
| 324 |
Surgery for bronchogenic carcinoma in the elderly: Immediate re-sults
|
|
|
1995
|
12 |
3 |
p. 300-
1 p.
|
artikel
|
| 325 |
Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma
|
|
|
1995
|
12 |
3 |
p. 300-
1 p.
|
artikel
|
| 326 |
Survival analysis of untreated patients with non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 287-
1 p.
|
artikel
|
| 327 |
Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): Response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C
|
|
|
1995
|
12 |
3 |
p. 307-
1 p.
|
artikel
|
| 328 |
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 303-
1 p.
|
artikel
|
| 329 |
Synergic action with octreotide and chemotherapy in Small-Cell Lung Cancer: A pilot study
|
|
|
1995
|
12 |
3 |
p. 313-314
2 p.
|
artikel
|
| 330 |
The bronchoscopic brachytherapy in early stage lung cancer of hilar type
|
|
|
1995
|
12 |
3 |
p. 319-
1 p.
|
artikel
|
| 331 |
The clinical significance serum N-POMC level in lung cancer patients
|
|
|
1995
|
12 |
3 |
p. 287-
1 p.
|
artikel
|
| 332 |
The comparison of CAP chemotherapy and radiotherapy to radio-therapy alone for resected lung cancer with positive margin or in-volved highest sampled paratracheal node (stage IIIA): LCSG 791
|
|
|
1995
|
12 |
3 |
p. 323-
1 p.
|
artikel
|
| 333 |
The correlation between bronchoscopic morphology and pathologic type in bron chogenic carcinoma
|
|
|
1995
|
12 |
3 |
p. 279-
1 p.
|
artikel
|
| 334 |
The early detection of second primary lung cancers by sputum immunostaining
|
|
|
1995
|
12 |
3 |
p. 288-
1 p.
|
artikel
|
| 335 |
The early detection of second primary lung cancers by sputum immunostaining
|
|
|
1995
|
12 |
3 |
p. 288-
1 p.
|
artikel
|
| 336 |
The prognostic value of argyrophil nucleolar organizer regions (AgNORs) and fibronectin antibody in stage I lung cancer
|
|
|
1995
|
12 |
3 |
p. 291-
1 p.
|
artikel
|
| 337 |
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model
|
|
|
1995
|
12 |
3 |
p. 274-275
2 p.
|
artikel
|
| 338 |
Therapeutic effect of carboplatin and etoposide combinative therapy on 123 lung cancer cases
|
|
|
1995
|
12 |
3 |
p. 309-310
2 p.
|
artikel
|
| 339 |
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation
|
|
|
1995
|
12 |
3 |
p. 304-
1 p.
|
artikel
|
| 340 |
The role of CT and MRI in staging of the mediastinum
|
|
|
1995
|
12 |
3 |
p. 288-
1 p.
|
artikel
|
| 341 |
The role of induction chemotherapy before radiation therapy in non-operative management of stage III NSCLC
|
|
|
1995
|
12 |
3 |
p. 321-322
2 p.
|
artikel
|
| 342 |
The role of intraoperative ultrasound in lung cancer patients
|
|
|
1995
|
12 |
3 |
p. 280-
1 p.
|
artikel
|
| 343 |
The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts
|
|
|
1995
|
12 |
3 |
p. 304-
1 p.
|
artikel
|
| 344 |
The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer
|
|
|
1995
|
12 |
3 |
p. 274-
1 p.
|
artikel
|
| 345 |
The role of radiotherapy in the treatment of stage III non-small cell lung cancer: A survey of clinical practices in Lombardy, Italy, by the Airo-Lombardia Cooperative Group
|
|
|
1995
|
12 |
3 |
p. 319-
1 p.
|
artikel
|
| 346 |
The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies
|
|
|
1995
|
12 |
3 |
p. 279-280
2 p.
|
artikel
|
| 347 |
The strategy for therapy of lung cancer
|
|
|
1995
|
12 |
3 |
p. 326-
1 p.
|
artikel
|
| 348 |
The tissue polypeptide antigen serum test in the peoperative evaluation of non-small cell lung cancer: Diagnostic yield and comparison with conventional staging methods
|
|
|
1995
|
12 |
3 |
p. 280-
1 p.
|
artikel
|
| 349 |
The value of bone marrow examination in small cell carcinoma of the lung
|
|
|
1995
|
12 |
3 |
p. 285-
1 p.
|
artikel
|
| 350 |
The value of combined assay of serum lung cancer associated anti-gens 3C,Ag and WLA-Ag1
|
|
|
1995
|
12 |
3 |
p. 292-
1 p.
|
artikel
|
| 351 |
The value of immunohistochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma
|
|
|
1995
|
12 |
3 |
p. 278-
1 p.
|
artikel
|
| 352 |
The value of measuring serum TPA levels in bronchopulmonary cancer. A comparative study with ACE, CA 19.9 and NSE levels
|
|
|
1995
|
12 |
3 |
p. 293-
1 p.
|
artikel
|
| 353 |
The value of neuroendocrine markers in non-small cell lung cancer: A comparative immunohistopathologic study
|
|
|
1995
|
12 |
3 |
p. 277-278
2 p.
|
artikel
|
| 354 |
The value of octreotide scintigraphy in patients with lung cancer
|
|
|
1995
|
12 |
3 |
p. 296-
1 p.
|
artikel
|
| 355 |
Three-dimensional conformal radiotherapy in bronchogenic carcinoma: Considerations for implementation
|
|
|
1995
|
12 |
3 |
p. 317-318
2 p.
|
artikel
|
| 356 |
Time-related effects of enzymatic disaggregation on model human lung carcinomas
|
|
|
1995
|
12 |
3 |
p. 269-
1 p.
|
artikel
|
| 357 |
TNFα determination in serum and pleural effusion in patients with lung cancer
|
|
|
1995
|
12 |
3 |
p. 285-
1 p.
|
artikel
|
| 358 |
Transforming growth factor-beta 1 (TGF-β1)- and β2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 293-
1 p.
|
artikel
|
| 359 |
Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid
|
|
|
1995
|
12 |
3 |
p. 276-
1 p.
|
artikel
|
| 360 |
Treatment of advanced non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 328-
1 p.
|
artikel
|
| 361 |
Treatment of brain metastases from primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 280-281
2 p.
|
artikel
|
| 362 |
Treatment of Non-Small cell lung cancer with ifosfamide (IFO) + 4′-epiadriamycin (EPI) + platinum vs. IFO + EPI: A GETLAC study
|
|
|
1995
|
12 |
3 |
p. 307-308
2 p.
|
artikel
|
| 363 |
Treatment of small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 327-
1 p.
|
artikel
|
| 364 |
Treatment of small cell lung cancer with combined modality treatment
|
|
|
1995
|
12 |
3 |
p. 319-
1 p.
|
artikel
|
| 365 |
Tumor angiogenesis in human lung adenocarcinoma
|
|
|
1995
|
12 |
3 |
p. 293-294
2 p.
|
artikel
|
| 366 |
Tumor doubling time and prognostic assessment of patients with primary lung cancer
|
|
|
1995
|
12 |
3 |
p. 294-
1 p.
|
artikel
|
| 367 |
Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 270-
1 p.
|
artikel
|
| 368 |
Tumor suppressor and immediate early transcription factor genes in non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 271-
1 p.
|
artikel
|
| 369 |
Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas
|
|
|
1995
|
12 |
3 |
p. 278-
1 p.
|
artikel
|
| 370 |
Videothoracoscopy and video-assisted small thoracotomy for the treatment of pulmonary malignancies
|
|
|
1995
|
12 |
3 |
p. 286-
1 p.
|
artikel
|
| 371 |
Vinorelbine (Navelbine)-A new agent for the treatment of non-small cell lung cancer: A summary
|
|
|
1995
|
12 |
3 |
p. 312-
1 p.
|
artikel
|
| 372 |
Vinorelbine (Navelbine)/carboplatin combination therapy: Dose intensification with granulocyte colony-stimulating factor
|
|
|
1995
|
12 |
3 |
p. 311-
1 p.
|
artikel
|
| 373 |
Vinorelbine (Navelbine) in non-small cell lung cancer: Future directions
|
|
|
1995
|
12 |
3 |
p. 311-
1 p.
|
artikel
|
| 374 |
Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer
|
|
|
1995
|
12 |
3 |
p. 311-312
2 p.
|
artikel
|
| 375 |
What were the issues of surgical importance in lung cancer treatment in 1977; and how did they change over time?
|
|
|
1995
|
12 |
3 |
p. 300-
1 p.
|
artikel
|
| 376 |
Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer
|
|
|
1995
|
12 |
3 |
p. 293-
1 p.
|
artikel
|
Tijdschrift beschrijving